IP
NVO

Indivisible Partners’s Novo Nordisk NVO Stock Holding History

Indivisible Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Buy
+4,910
New +$211K 0.01% 577
2026
Q1 		– Sell
-9,466
Closed -$482K – 503
2025
Q4 		$482K Buy
+9,466
New +$484K 0.05% 258

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Indivisible Partners's NVO Position: Q2 2026 in Review

Indivisible Partners opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,910 shares worth $235K. The stake represents 0.01% of the portfolio and ranks #577 among its holdings. This is a return to the name: Indivisible Partners previously reported a position in NVO as recently as Q4 2025.

Indivisible Partners first reported a position in NVO in Q4 2025 and has held it in 2 quarters since. The position peaked at $482K in Q4 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Indivisible Partners held 4,910 shares of Novo Nordisk worth $235K as of Q2 2026.
  • Novo Nordisk was a new Indivisible Partners position in Q2 2026.
  • Novo Nordisk made up 0.01% of Indivisible Partners's portfolio in Q2 2026, its #577 holding.
  • Indivisible Partners first reported a position in Novo Nordisk in Q4 2025 and has held it in 2 quarters since.
  • Indivisible Partners's Novo Nordisk position peaked at $482K in Q4 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Indivisible Partners's 13F filing for Q2 2026, filed 4 Aug 2026.